NORTHVALE, NJ / ACCESSWIRE / April 29, 2021 / Elite Prescribed drugs, Inc. (“Elite” or the “Firm”) (OTCQB:ELTP), a specialty pharmaceutical business establishing and manufacturing market generic solutions, introduced currently that Marc Bregman, CPA, has been appointed as Main Money Officer (CFO), productive May well 17, 2021. Mr. Bregman and will report to Elite’s President and CEO, Nasrat Hakim.
Mr. Bregman has extra than 27 many years of economical and operational practical experience, together with positions as Controller at Langan Engineering & Environmental Providers and Controller at Chemtrade Logistics. He held corporate economical positions at Chemetall and National Starch & Chemical Business and was a supervisor and senior auditor at Ernst & Younger. Mr. Bregman provides working experience in economical accounting, economical planning & investigation, governance & compliance, money auditing, Sarbanes-Oxley Act (SOX) compliance, and price accounting.
“Marc is a terrific addition to Elite’s senior management group. Marc’s prosperity of hugely applicable encounter and exemplary skills in money and operational management will be an massive benefit to enable Elite in meeting our present-day and upcoming targets as we mature our company,” reported Nasrat Hakim. “We welcome Marc to our crew.”
Mr. Bregman has a Bachelor’s diploma in Accounting from William Paterson Faculty and a Master of Science in Enterprise degree from the Martin Tuchman College of Administration at the New Jersey Institute of Technologies. He is a Accredited General public Accountant (CPA).
About Elite Prescribed drugs, Inc.
Elite Prescription drugs, Inc. is a specialty pharmaceutical business which develops area of interest generic goods. Elite specializes in developing and manufacturing oral, managed-release drug products and solutions. Elite owns various generic merchandise which have been accredited to Lannett Enterprise, Glenmark Pharmaceuticals, Inc., and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing positioned in Northvale, NJ.
This push release consists of “forward-searching statements” in just the this means of the Non-public Securities Litigation Reform Act of 1995, which includes, devoid of limitation, those associated to the effects, if any, on long term benefits, efficiency, or other expectations that may well have some correlation to the subject make any difference of this press release. Viewers are cautioned that this kind of forward-hunting statements require, without limitation, threats, uncertainties, and other elements not underneath the command of Elite, which may lead to real success, general performance, or achievements of Elite to be materially diverse from the effects, general performance, or other anticipations that may well be implied by these ahead-wanting statements. These ahead-on the lookout statements may well include statements relating to the anticipated timing of acceptance, if at all, of merchandise by the Fda, and the steps the Food and drug administration may possibly involve of Elite in purchase to get hold of these types of approvals. These forward-wanting statements are not ensures of long term action or performance. These challenges and other things are reviewed, without limitation, in Elite’s filings with the Securities and Exchange Commission, which include its reports on varieties 10-K, 10-Q, and 8-K. Elite is less than no obligation to update or change its forward-looking statements, no matter whether as a final result of new info, foreseeable future events, or if not.
Make contact with:
For Elite Pharmaceuticals, Inc.
Dianne Will, Trader Relations, 518-398-6222
[email protected]
www.elitepharma.com
Supply: Elite Prescription drugs, Inc.
See supply edition on accesswire.com:
https://www.accesswire.com/643272/Elite-Prescription drugs-Inc-Names-Marc-Bregman-as-Main-Economic-Officer
